Heparin Rebound: An In-Depth Review

Area of Science:

• Cardiovascular Surgery
• Anesthesiology
• Pharmacology

Background:

• The concept of "heparin rebound" suggests heparin returns to circulation postoperatively, necessitating additional protamine to prevent bleeding.
• This belief has historically guided empiric protamine administration based on prolonged coagulation tests or bleeding after cardiac surgery with cardiopulmonary bypass.

Purpose of the Study:

• To critically review the literature on heparin rebound and its association with postoperative bleeding after cardiac surgery.
• To provide a modern, evidence-based understanding of heparin rebound to guide clinical practice.

Main Methods:

• Comprehensive literature search using PubMed with MeSH terms: heparin rebound, heparin reversal, protamine, platelet factor 4, and polybrene.
• Review of relevant English language articles and their internal citations.
• Analysis of studies with varying methodologies and definitions of "heparin rebound" and "adequate reversal".

Main Results:

• Over 60 years of literature provide weak evidence that heparin rebound is a significant cause of postoperative bleeding after cardiac surgery.
• While low heparin activity can be detected postoperatively in some patients, studies show no correlation with actual bleeding.
• Inconsistent definitions and methodologies across studies complicate the understanding of heparin rebound.

Conclusions:

• The clinical significance of heparin rebound as a cause of postoperative bleeding is questionable.
• An evidence-based approach, rather than empiric protamine administration, is recommended for managing postoperative bleeding.
• Recommendations are provided for current clinical practice, considering different management strategies.